Osteosarcoma of the jaws in Koreans: Analysis of 26 cases

Hye In Jeong, Mi Jee Lee, Woong Nam, In Ho Cha, Hyung Jun Kim

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Objectives: In order to assess clinical behavior, response to treatment, and factors influencing prognosis of Korean patients with osteosarcoma of the jaws (OSJ). Materials and Methods: A retrospective study of clinical, and pathological records of 26 patients with OSJ treated at the Department of Oral and Maxillofacial Surgery in Yonsei University Dental Hospital from 1990 to March 2017. Results: Of 26 patients, there were 9 men (34.6%) and 17 women (65.4%). Twenty-one of 26 patients had osteosarcoma of the mandible, and 5 of 26 patients had osteosarcoma of the maxilla. The histopathology of OSJ is highly variable, ranging from chondroblastic type (6 out of 26), osteoblastic type (10 out of 26), fibroblastic type (2 out of 26), to the rare variants like mixed type, small cell osteosarcoma types and more. All patients underwent gross total excision and only a few patients underwent neoadjuvant chemotherapy. Postoperative chemotherapy was given to most of the patients as adjuvant treatment or in combination with radiotherapy. The overall survival rate was 73.1% with an overall 2-year survival rate of 83.3%. The overall 5-,10-,15-year survival rates in this study were 73.5%, 73.5%, 49%, respectively. Using Kaplan-Meier analysis with log rank tests, the size of tumor (T-stage), and resection margins were found to affect the survival rate significantly. The chemotherapy was not significantly associated with improved survival rate. Conclusion: Surgical resection with a clear margin is the most important factor in disease survival. The role of chemotherapy and radiotherapy in OSJ remains controversial, and deserves further studies.

Original languageEnglish
Pages (from-to)312-317
Number of pages6
JournalJournal of the Korean Association of Oral and Maxillofacial Surgeons
Volume43
Issue number5
DOIs
Publication statusPublished - 2017 Oct

Fingerprint

Osteosarcoma
Jaw
Survival Rate
Drug Therapy
Oral Surgery
Radiotherapy
Kaplan-Meier Estimate
Maxilla
Mandible
Tooth
Retrospective Studies
Survival
Therapeutics

All Science Journal Classification (ASJC) codes

  • Surgery
  • Oral Surgery

Cite this

Jeong, Hye In ; Lee, Mi Jee ; Nam, Woong ; Cha, In Ho ; Kim, Hyung Jun. / Osteosarcoma of the jaws in Koreans : Analysis of 26 cases. In: Journal of the Korean Association of Oral and Maxillofacial Surgeons. 2017 ; Vol. 43, No. 5. pp. 312-317.
@article{fefb056a6af04acf89cf58668d688a92,
title = "Osteosarcoma of the jaws in Koreans: Analysis of 26 cases",
abstract = "Objectives: In order to assess clinical behavior, response to treatment, and factors influencing prognosis of Korean patients with osteosarcoma of the jaws (OSJ). Materials and Methods: A retrospective study of clinical, and pathological records of 26 patients with OSJ treated at the Department of Oral and Maxillofacial Surgery in Yonsei University Dental Hospital from 1990 to March 2017. Results: Of 26 patients, there were 9 men (34.6{\%}) and 17 women (65.4{\%}). Twenty-one of 26 patients had osteosarcoma of the mandible, and 5 of 26 patients had osteosarcoma of the maxilla. The histopathology of OSJ is highly variable, ranging from chondroblastic type (6 out of 26), osteoblastic type (10 out of 26), fibroblastic type (2 out of 26), to the rare variants like mixed type, small cell osteosarcoma types and more. All patients underwent gross total excision and only a few patients underwent neoadjuvant chemotherapy. Postoperative chemotherapy was given to most of the patients as adjuvant treatment or in combination with radiotherapy. The overall survival rate was 73.1{\%} with an overall 2-year survival rate of 83.3{\%}. The overall 5-,10-,15-year survival rates in this study were 73.5{\%}, 73.5{\%}, 49{\%}, respectively. Using Kaplan-Meier analysis with log rank tests, the size of tumor (T-stage), and resection margins were found to affect the survival rate significantly. The chemotherapy was not significantly associated with improved survival rate. Conclusion: Surgical resection with a clear margin is the most important factor in disease survival. The role of chemotherapy and radiotherapy in OSJ remains controversial, and deserves further studies.",
author = "Jeong, {Hye In} and Lee, {Mi Jee} and Woong Nam and Cha, {In Ho} and Kim, {Hyung Jun}",
year = "2017",
month = "10",
doi = "10.5125/jkaoms.2017.43.5.312",
language = "English",
volume = "43",
pages = "312--317",
journal = "Journal of the Korean Association of Oral and Maxillofacial Surgeons",
issn = "2234-7550",
publisher = "Korean Association of Oral and Maxillofacial Surgeons",
number = "5",

}

Osteosarcoma of the jaws in Koreans : Analysis of 26 cases. / Jeong, Hye In; Lee, Mi Jee; Nam, Woong; Cha, In Ho; Kim, Hyung Jun.

In: Journal of the Korean Association of Oral and Maxillofacial Surgeons, Vol. 43, No. 5, 10.2017, p. 312-317.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Osteosarcoma of the jaws in Koreans

T2 - Analysis of 26 cases

AU - Jeong, Hye In

AU - Lee, Mi Jee

AU - Nam, Woong

AU - Cha, In Ho

AU - Kim, Hyung Jun

PY - 2017/10

Y1 - 2017/10

N2 - Objectives: In order to assess clinical behavior, response to treatment, and factors influencing prognosis of Korean patients with osteosarcoma of the jaws (OSJ). Materials and Methods: A retrospective study of clinical, and pathological records of 26 patients with OSJ treated at the Department of Oral and Maxillofacial Surgery in Yonsei University Dental Hospital from 1990 to March 2017. Results: Of 26 patients, there were 9 men (34.6%) and 17 women (65.4%). Twenty-one of 26 patients had osteosarcoma of the mandible, and 5 of 26 patients had osteosarcoma of the maxilla. The histopathology of OSJ is highly variable, ranging from chondroblastic type (6 out of 26), osteoblastic type (10 out of 26), fibroblastic type (2 out of 26), to the rare variants like mixed type, small cell osteosarcoma types and more. All patients underwent gross total excision and only a few patients underwent neoadjuvant chemotherapy. Postoperative chemotherapy was given to most of the patients as adjuvant treatment or in combination with radiotherapy. The overall survival rate was 73.1% with an overall 2-year survival rate of 83.3%. The overall 5-,10-,15-year survival rates in this study were 73.5%, 73.5%, 49%, respectively. Using Kaplan-Meier analysis with log rank tests, the size of tumor (T-stage), and resection margins were found to affect the survival rate significantly. The chemotherapy was not significantly associated with improved survival rate. Conclusion: Surgical resection with a clear margin is the most important factor in disease survival. The role of chemotherapy and radiotherapy in OSJ remains controversial, and deserves further studies.

AB - Objectives: In order to assess clinical behavior, response to treatment, and factors influencing prognosis of Korean patients with osteosarcoma of the jaws (OSJ). Materials and Methods: A retrospective study of clinical, and pathological records of 26 patients with OSJ treated at the Department of Oral and Maxillofacial Surgery in Yonsei University Dental Hospital from 1990 to March 2017. Results: Of 26 patients, there were 9 men (34.6%) and 17 women (65.4%). Twenty-one of 26 patients had osteosarcoma of the mandible, and 5 of 26 patients had osteosarcoma of the maxilla. The histopathology of OSJ is highly variable, ranging from chondroblastic type (6 out of 26), osteoblastic type (10 out of 26), fibroblastic type (2 out of 26), to the rare variants like mixed type, small cell osteosarcoma types and more. All patients underwent gross total excision and only a few patients underwent neoadjuvant chemotherapy. Postoperative chemotherapy was given to most of the patients as adjuvant treatment or in combination with radiotherapy. The overall survival rate was 73.1% with an overall 2-year survival rate of 83.3%. The overall 5-,10-,15-year survival rates in this study were 73.5%, 73.5%, 49%, respectively. Using Kaplan-Meier analysis with log rank tests, the size of tumor (T-stage), and resection margins were found to affect the survival rate significantly. The chemotherapy was not significantly associated with improved survival rate. Conclusion: Surgical resection with a clear margin is the most important factor in disease survival. The role of chemotherapy and radiotherapy in OSJ remains controversial, and deserves further studies.

UR - http://www.scopus.com/inward/record.url?scp=85045378381&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85045378381&partnerID=8YFLogxK

U2 - 10.5125/jkaoms.2017.43.5.312

DO - 10.5125/jkaoms.2017.43.5.312

M3 - Article

AN - SCOPUS:85045378381

VL - 43

SP - 312

EP - 317

JO - Journal of the Korean Association of Oral and Maxillofacial Surgeons

JF - Journal of the Korean Association of Oral and Maxillofacial Surgeons

SN - 2234-7550

IS - 5

ER -